Solta Medical Inc

Type: Company
Name: Solta Medical Inc
Nationality: United States
Web Address: http://www.solta.com/
First reported Apr 10 2014 - Updated Apr 11 2014 - 3 reports

Bacterin Adds 2 VPs

Bacterin International Holdings, Inc., a company focusing on bone graft material and coatings for medical applications, announced the addition of Jimmy Bornheimer, Vice President of Finance, and Stephen Smith, Vice President of Regulatory and Quality ... [Published Individual.com - Apr 11 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Baxter adds 30 jobs in Malta | Medtech personnel moves for the week of Apr. 7, 2014

by Arezu SarvestaniMalta regulators announced this week that healthcare titan Baxter plans to add 30 additional jobs in the country.Baxter will add new members to its research & development workforce over the next 18 months and plans to further invest ... [Published MassDevice - Apr 09 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Bacterin Announces the Addition of Two Vice Presidents

BELGRADE, Mont.--(BUSINESS WIRE)-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of Jimmy Bornheimer, ... [Published CNBC - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Z-Medica Taps Stephen Fanning as CEO

Stephen J. Fanning has been appointed president and chief executive officer of Z-Medica Corp., a privately held developer of blood clotting technology products based in Wallingford, Connecticut, it was announced here recently by Doug Schillinger, Z-Medica's ... [Published Individual.com - Apr 08 2014]
First reported Apr 06 2014 - Updated Apr 06 2014 - 1 reports

Escobedo Skin Center is Pleased Offer Thermage NXT

The Escobedo Skin Center implements the latest cosmetic technology offered by Solta Medical--the New Thermage NXT.The new FDA-approved Thermage NXT uses mono-polar capacitive coupling to volumetrically heat skin to induce collagen remodeling in three ... [Published Free Press Release - Apr 06 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Z-Medica taps ex-Solta Medical CEO Fanning | Personnel Moves

by Stephen Fanning, the former CEO of Solta Medical, is Z-Medica's new chief.Z-Medica said it named Stephen Fanning, the former CEO of Solta Medical, to be its new chief executive.Wallingford, Conn.-based Z-Medica is developing blood clotting technologies ... [Published MassDevice - Apr 03 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 2 reports

Z-Medica taps Calif. leader

Submitted photoZ-Medica President and CEO Stephen FanningWallingford medical device manufacturer Z-Medica Inc. said it has hired Stephen J. Fanning as president and CEO.The privately-held company, which makes blood clotting products under the name QuickClot, ... [Published Hartford Business Journal - Apr 03 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Valeant's CEO, a crackerjack cost-cutter, seeks more 'fat' companies to buy

Back in January, Valeant Pharmaceuticals' CEO J. Michael Pearson couldn't say how he intended to reach his lofty goal of cracking the list of top 5 drugmakers worldwide. Now, he's offering new details about his acquisition blueprints, and they include ... [Published FiercePharma - Mar 20 2014]
First reported Mar 10 2014 - Updated Mar 10 2014 - 2 reports

Ethos Spa Skin and Laser Centers Now Offering Advanced Fraxel Restore$ Treatments to Erase Signs of Aging

now offers advanced to reverse signs of aging and diminish acne scarring. Hardik Soni M.D., Medical Director of Ethos Spa and Laser Centers, provides Fraxel treatments at both Ethos Spa Centers in Summit and Englewood, New Jersey for women and men looking ... [Published Digital Journal - Mar 10 2014]
First reported Feb 03 2014 - Updated Feb 04 2014 - 2 reports

Post/wire say Valeant to buy PreCision Dermatology

Close 2014-02-03 C$ 148.11 Recent Sedar DocumentsView Original Document The Financial Post reports in its Tuesday edition Valeant Pharmaceuticals International has agreed to acquire privately held PreCision Dermatology for $475-million in cash to strengthen ... [Published Stockwatch - Feb 04 2014]
First reported Jan 15 2014 - Updated Jan 15 2014 - 1 reports

Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.

VALEANT PHARMACEUTICALS INTERNAT Symbol U : VRX Recent Sedar Documents Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. ... [Published Stockwatch - Jan 15 2014]
First reported Dec 16 2013 - Updated Dec 17 2013 - 1 reports

Valeant (VRX) To Buy Solta Medical (SLTM) For $236 Million in Cash

NEW YORK (TheStreet) -- Valeant Pharmaceuticals  announced today that will acquire Solta Medical  for about $236 million in cash. The deal will see Valeant purchase all common stock of Solta for $2.92 per share, a 40% premium over the medical technology ... [Published The Street Latest - Dec 16 2013]

Quotes

"Mr. Bornheimer and Mr. Smith bring extensive experience in their areas of expertise, and will fill key roles as Bacterin grows" said Dan Goldberger, Bacterin President and CEO
"QuikClot products have been adopted by the US military and are gaining awareness in a variety of healthcare and emergency response settings. We have the ability to increase our growth rate by applying the Company's unique technology to address unmet medical needs in a significant number of major markets including hospitals, military, first responders, law enforcement, institutional settings and consumer retail outlets. In addition, our leadership in blood clotting technology creates the opportunity to expand our platform with our current and potential customer base. I am excited about the Z-Medica opportunity and working with the entire team to capitalize on our potential" said Fanning
...told Bloomberg, he's trying for another Bausch + Lomb-sized deal for 2014, in particular eyeing those companies with problems Valeant can fix. "We like companies that are fat, lots of costs that we can take out" he told the news service...
...latest is consistent with comments by senior executives in October that the drugmaker was seeking small, cash-based acquisitions in the near term. "While we note that PreCision is merely a small step toward Valeant's more ambitious goals of adding $150 billion in market capitalization by 2016, we think the acquisition, much like Solta's recent acquisition, makes strategic sense" said Stifel Nicolaus analyst Annabel Samimy, in a note to clients...

More Content

All (37) | News (22) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (11)
sort by: Date | Relevance
Bacterin Adds 2 VPs [Published Individual.com - Apr 11 2014]
Bacterin Reports the Addition of 2 VPs [Published Individual.com - Apr 11 2014]
Bacterin International appoints two new vice pr... [Published Individual.com - Apr 10 2014]
Baxter adds 30 jobs in Malta | Medtech personne... [Published MassDevice - Apr 09 2014]
Bacterin Announces the Addition of Two Vice Pre... [Published CNBC - Apr 08 2014]
Z-Medica Taps Stephen Fanning as CEO [Published Individual.com - Apr 08 2014]
Escobedo Skin Center is Pleased Offer Thermage NXT [Published Free Press Release - Apr 06 2014]
Z-Medica taps ex-Solta Medical CEO Fanning | Pe... [Published MassDevice - Apr 03 2014]
Z-Medica taps Calif. leader [Published Hartford Business Journal - Apr 03 2014]
PE-backed Z-Medica names new president and CEO [Published PE Hub Blog - Apr 03 2014]
Stephen J. Fanning Appointed President & CEO of... [Published Enhanced Online News - Apr 03 2014]
Valeant's CEO, a crackerjack cost-cutter, seeks... [Published FiercePharma - Mar 20 2014]
Ethos Spa Skin and Laser Centers Now Offering A... [Published Digital Journal - Mar 10 2014]
Ethos Spa Skin and Laser Centers Now Offering A... [Published PRWeb - Mar 10 2014]
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Post/wire say Valeant to buy PreCision Dermatology [Published Stockwatch - Feb 04 2014]
Valeant to buy PreCision Dermatology for $475 m... [Published PE Hub Blog - Feb 03 2014]
Monday Deal Review: January 27, 2014 [Published The Cross-Border Biotech Blog - Jan 27 2014]
Valeant Pharmaceuticals International, Inc. Com... [Published Financial Services - Jan 23 2014]
Valeant's Solta offer taken up by 85% of shares [Published Stockwatch - Jan 23 2014]
Solta Medical, Inc. Stockholders Encouraged to ... [Published Stockwatch - Jan 17 2014]
Solta Medical, Inc. Stockholders Encouraged to ... [Published Financial Services - Jan 17 2014]
Technical Update on Health Care Sector: Solta M... [Published Financial Services - Jan 16 2014]
Valeant Pharmaceuticals Announces Receipt Of An... [Published Stockwatch - Jan 15 2014]
Photo Release -- NovaBay Pharmaceuticals Appoin... [Published GlobeNewswire: Acquisitions News - Jan 09 2014]
Lifshitz Law Firm Announces Investigation of Co... [Published Financial Services - Dec 30 2013]
INVESTOR ALERT Levi & Korsinsky, LLP Announces ... [Published Financial Services - Dec 18 2013]
Valeant Pharma to buy Solta Medical for $250m [Published Pharmaceutical Business Review - Dec 18 2013]
Ryan & Maniskas, LLP Announces Investigation of... [Published Financial Services - Dec 17 2013]
Harwood Feffer LLP Announces Investigation of S... [Published Financial Services - Dec 17 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
PE-backed Z-Medica names new president and CEO [Published PE Hub Blog - Apr 03 2014]
Z-Medica , which is backed by DW Healthcare Partners , has hired Stephen J. Fanning as president and CEO. Previously, Fanning was the chairman, president and CEO of Solta Medical . Based in Wallingford, Conn., Z-Medical is a maker of blood clotting ...
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Merck & Co. Inc.’s Feb. 5 announcement that it is collaborating with three companies to test various combinations of its investigational oncology compound MK-3475 with their drugs highlights the extent to which the big pharma is committed to building ...
Valeant to buy PreCision Dermatology for $475 m... [Published PE Hub Blog - Feb 03 2014]
(Reuters) - Valeant Pharmaceuticals International Inc said on Monday it has agreed to acquire privately held PreCision Dermatology Inc for $475 million in cash to strengthen its skin products business. The deal, which is set to close in the first ...
Monday Deal Review: January 27, 2014 [Published The Cross-Border Biotech Blog - Jan 27 2014]
  Welcome to your Monday Biotech Deal Review for Janary 27, 2014! This week saw Valeant complete thier acquisition of Solta Medical, Inc. for USD$250 million. Solta Medical provides treatment technologies for aesthetic care options at the consumer and ...
1

Press Releases

sort by: Date | Relevance
Valeant Pharmaceuticals International, Inc. Com... [Published Financial Services - Jan 23 2014]
Solta Medical, Inc. Stockholders Encouraged to ... [Published Financial Services - Jan 17 2014]
Technical Update on Health Care Sector: Solta M... [Published Financial Services - Jan 16 2014]
Photo Release -- NovaBay Pharmaceuticals Appoin... [Published GlobeNewswire: Acquisitions News - Jan 09 2014]
Lifshitz Law Firm Announces Investigation of Co... [Published Financial Services - Dec 30 2013]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.